1. Home
  2. BOLT vs BNZI Comparison

BOLT vs BNZI Comparison

Compare BOLT & BNZI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLT
  • BNZI
  • Stock Information
  • Founded
  • BOLT 2015
  • BNZI 2016
  • Country
  • BOLT United States
  • BNZI United States
  • Employees
  • BOLT N/A
  • BNZI N/A
  • Industry
  • BOLT Biotechnology: Pharmaceutical Preparations
  • BNZI
  • Sector
  • BOLT Health Care
  • BNZI
  • Exchange
  • BOLT Nasdaq
  • BNZI Nasdaq
  • Market Cap
  • BOLT 10.4M
  • BNZI 11.5M
  • IPO Year
  • BOLT 2021
  • BNZI N/A
  • Fundamental
  • Price
  • BOLT $5.75
  • BNZI $2.91
  • Analyst Decision
  • BOLT Buy
  • BNZI Strong Buy
  • Analyst Count
  • BOLT 3
  • BNZI 1
  • Target Price
  • BOLT $47.50
  • BNZI $30.00
  • AVG Volume (30 Days)
  • BOLT 39.8K
  • BNZI 512.3K
  • Earning Date
  • BOLT 11-11-2025
  • BNZI 11-13-2025
  • Dividend Yield
  • BOLT N/A
  • BNZI N/A
  • EPS Growth
  • BOLT N/A
  • BNZI N/A
  • EPS
  • BOLT N/A
  • BNZI N/A
  • Revenue
  • BOLT $4,167,000.00
  • BNZI $9,021,543.00
  • Revenue This Year
  • BOLT N/A
  • BNZI $260.63
  • Revenue Next Year
  • BOLT N/A
  • BNZI $35.01
  • P/E Ratio
  • BOLT N/A
  • BNZI N/A
  • Revenue Growth
  • BOLT N/A
  • BNZI 107.94
  • 52 Week Low
  • BOLT $4.59
  • BNZI $2.08
  • 52 Week High
  • BOLT $14.36
  • BNZI $38.00
  • Technical
  • Relative Strength Index (RSI)
  • BOLT 52.63
  • BNZI 48.20
  • Support Level
  • BOLT $5.62
  • BNZI $2.73
  • Resistance Level
  • BOLT $6.38
  • BNZI $3.98
  • Average True Range (ATR)
  • BOLT 0.43
  • BNZI 0.35
  • MACD
  • BOLT 0.01
  • BNZI -0.02
  • Stochastic Oscillator
  • BOLT 41.53
  • BNZI 17.69

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

About BNZI Banzai International Inc.

Banzai International Inc is a marketing technology (MarTech) company that produces data-driven marketing and sales solutions for businesses of all sizes. Its mission is to help its customers accomplish their mission by enabling marketing, sales and customer engagement outcomes. The company has two reportable operating segments, Banzai Operating and OpenReel. The company's segments deliver SaaS tools that leverage data, analytics, and AI to provide marketing and sales solutions for business of all size. it derives maximum revenue from Banzai Operating segment. Geographically, it operates in Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific.

Share on Social Networks: